Anemia in Adults With Congenital Heart Disease Relates to Adverse Outcome
Konstantinos Dimopoulos, MD, MSc, PhD*, ,*,
Gerhard-Paul Diller, MD, PhD*,,
Georgios Giannakoulas, MD, PhD*,
Ricardo Petraco, MD*,
Aikaterini Chamaidi, MD*,
Evaggelia Karaoli, MD*,
Michael Mullen, MD*,
Lorna Swan, MD, PhD*,
Massimo F. Piepoli, MD, PhD,
Philip A. Poole-Wilson, MD,
Darrel P. Francis, MA and
Michael A. Gatzoulis, MD, PhD*
* Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, United Kingdom
Department of Clinical Cardiology, National Heart and Lung Institute, Imperial College School of Medicine, London, United Kingdom
International Centre for Cardiocirculatory Health, St. Mary's Hospital, London, United Kingdom
View larger version (22K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2 Prevalence of Anemia
The prevalence of anemia in various adults with congenital heart disease diagnostic groups. ccTGA = congenitally corrected transposition of great arteries.
|
|
View larger version (19K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 4 Univariate Predictors of Mortality
Univariate predictors of death: hazard ratio and 95% confidence interval. ACEi/ARB = angiotensin-converting enzyme inhibitor/angiotensin receptor blockers; NYHA = New York Heart Association.
|
|
|
